Reply to “Clarifying AIDS vaccine trial guidelines”

Allegiance or Fidelity? A Clarifying Reply

Recently, in the journal Clinical Psychology: Science and Practice, there appeared a systematic review (Blair, Marcus, & Boccaccini, 2008) accompanied by a commentary (Lilienfeld & Jones, 2008) suggesting an ‘‘allegiance effect’’ in the reporting of the predictive accuracy of actuarial risk assessment systems. The authors of these two articles suggested some possible errors or misrepresentation...

AIDS—Bristol Virologists Reply to Dr Seale

Yellow fever vaccine-reply to S. arya

Letters tion centers in Lagos was fully potent, but potency in Osun and Oyo was 016 log 10 to 0.22 log 10 lower than the stipulated level (2). Furthermore, the titer of two vaccine lots that had been frozen after reconstitution from their lyophilized state dropped from the initial 3.15 log 10 to 3.53 log 10 to zero. If the United States were to implement an extended strategy, similar studies of...

The ethical design of an AIDS vaccine trial in Africa.

In 1987 in Zaire, a French investigator and a small group of Zairians were immunized with a French investigational AIDS vaccine. This action leads to questioning whether different sociocultural settings should have different research ethics applied, especially on pandemic diseases. Another question is to clarify the valid reasons for conducting an AIDS trial in Africa. The design of an AIDS ...

COMMENTARY Clarifying the Foundations of Evolutionary Psychology: A Reply to Lloyd and Feldman

Lloyd and Feldman’s (this issue) continuing commentary on our recent target article and rejoinder (Ellis & Ketelaar, 2000; Ketelaar & Ellis, 2000) focuses on two overarching issues. First, Lloyd and Feldman claim that our description of the core metatheoretical assumptions of modern evolutionary theory overemphasizes the role of inclusive fitness (i.e., the so-called selfish gene approach) at t...